Laryngoscope Investig Otolaryngol. 2017 May 20;2(4):194-198. doi: 10.1002/lio2.83. eCollection 2017 Aug.
Cell line dependent expression of EpCAM influences the detection of circulating tumor cells with CellSearch.
Laryngoscope investigative otolaryngology
Gustaf Lindgren, Johan Wennerberg, Lars Ekblad
Affiliations
Affiliations
- Division of Oto-rhino-laryngology, Head and Neck Surgery Lund Sweden.
- Department of Clinical Sciences Lund Skåne University Hospital, Lund University Lund Sweden.
- Division of Oncology and Pathology Lund Sweden.
- Department of Clinical Sciences Lund Faculty of Medicine, Lund University Lund Sweden.
PMID: 28894840
PMCID: PMC5562942 DOI: 10.1002/lio2.83
Abstract
OBJECTIVES: The existence of circulating tumor cells has emerged as an important factor for prognosis and survival. The CellSearch method is the only circulating tumor cell detection method approved by the US Food and Drug Administration for clinical use. It relies on the detection of EpCAM (epithelial cell adhesion molecule) and is approved for colon cancer, breast cancer and prostate cancer. We now investigated whether CellSearch can be used to quantify circulating tumor cells in head and neck squamous cell cancer.
STUDY DESIGN AND METHODS: In this study, we investigated the expression of EpCAM in 12 head and neck squamous cell cancer cell lines using Western blot and how this affected their detectability with CellSearch in peripheral blood.
RESULTS: We found a great variation in the expression of EpCAM between our head and neck squamous cell cancer cell lines. This was accompanied by variations in counting efficiency.
CONCLUSION: We suggest that for reliable quantification of circulating tumor cells in blood from patients with head and neck squamous cell cancer cell, an epitope independent method is preferable.
LEVEL OF EVIDENCE: NA.
Keywords: CellSearch; EpCAM; Head and neck squamous cell carcinoma; circulating tumor cells; cytokeratin
References
- Clin Cancer Res. 2008 Oct 1;14(19):6302-9 - PubMed
- Lancet Oncol. 2014 Apr;15(4):406-14 - PubMed
- PLoS One. 2014 Dec 05;9(12):e113706 - PubMed
- J Clin Oncol. 2008 Jul 1;26(19):3213-21 - PubMed
- Cancer Genet Cytogenet. 2002 Jan 15;132(2):85-96 - PubMed
- Sci Rep. 2015 Jul 17;5:12270 - PubMed
- J Pathol. 2001 Jul;194(3):298-302 - PubMed
- Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4218-24 - PubMed
- Oral Oncol. 2010 Jul;46(7):485-91 - PubMed
- J Proteome Res. 2011 Mar 4;10(3):1416-9 - PubMed
- Anticancer Res. 2006 Jan-Feb;26(1A):153-8 - PubMed
- J Cell Biol. 1997 Dec 1;139(5):1337-48 - PubMed
- Clin Cancer Res. 2016 May 15;22(10):2583-93 - PubMed
- Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e685-90 - PubMed
- Oncotarget. 2016 Nov 1;7(44):71223-71234 - PubMed
- N Engl J Med. 2004 Aug 19;351(8):781-91 - PubMed
- BMC Cancer. 2016 Jul 08;16:433 - PubMed
- Med Oncol. 2015 May;32(5):164 - PubMed
- PLoS One. 2015 Jul 17;10(7):e0132901 - PubMed
- Clin Cancer Res. 2004 Oct 15;10(20):6897-904 - PubMed
- Ann Oncol. 2009 Jul;20(7):1223-9 - PubMed
- Anal Chem. 2015 Sep 15;87(18):9322-8 - PubMed
- Anticancer Res. 1999 May-Jun;19(3B):2237-42 - PubMed
- Int J Cancer. 2015 Jun 1;136(11):2515-23 - PubMed
- Ann Transl Med. 2014 Nov;2(11):108 - PubMed
- Anticancer Res. 2015 Jul;35(7):3953-60 - PubMed
- BMC Cancer. 2013 Jan 25;13:33 - PubMed
- Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
- Eur Arch Otorhinolaryngol. 2013 Sep;270(10 ):2745-9 - PubMed
- Laryngoscope. 2016 Jun;126(6):E213-7 - PubMed
- Ann Oncol. 2011 Aug;22(8):1878-85 - PubMed
- Head Neck. 2012 Oct;34(10):1440-4 - PubMed
- Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1274-9 - PubMed
Publication Types